R01 DK054044/DK/NIDDK NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2002	1
2006	3
2007	1
2008	1
2009	1
2010	1
2011	2
2012	2
2015	1
2024	0

1

Nicks KM, Fowler TW, Gaddy D. Nicks KM, et al. Curr Osteoporos Rep. 2010 Jun;8(2):60-7. doi: 10.1007/s11914-010-0014-3. Curr Osteoporos Rep. 2010. PMID: 20425612 Review.

2

Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

Nicks KM, Perrien DS, Akel NS, Suva LJ, Gaddy D. Nicks KM, et al. Mol Cell Endocrinol. 2009 Oct 30;310(1-2):11-20. doi: 10.1016/j.mce.2009.07.001. Epub 2009 Jul 15. Mol Cell Endocrinol. 2009. PMID: 19615428 Free PMC article. Review.

3

Bone loss goes beyond estrogen.

Martin TJ, Gaddy D. Martin TJ, et al. Nat Med. 2006 Jun;12(6):612-3. doi: 10.1038/nm0606-612. Nat Med. 2006. PMID: 16761003 No abstract available.

4

Inhibin A enhances bone formation during distraction osteogenesis.

Perrien DS, Nicks KM, Liu L, Akel NS, Bacon AW, Skinner RA, Swain FL, Aronson J, Suva LJ, Gaddy D. Perrien DS, et al. J Orthop Res. 2012 Feb;30(2):288-95. doi: 10.1002/jor.21501. Epub 2011 Aug 1. J Orthop Res. 2012. PMID: 21809377 Free PMC article.

5

Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment.

Fowler TW, McKelvey KD, Akel NS, Vander Schilden J, Bacon AW, Bracey JW, Sowder T, Skinner RA, Swain FL, Hogue WR, Leblanc DB, Gaddy D, Wenger GR, Suva LJ. Fowler TW, et al. PLoS One. 2012;7(8):e42967. doi: 10.1371/journal.pone.0042967. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22916188 Free PMC article.

6

Inhibin and the regulation of bone mass.

Gaddy D. Gaddy D. Curr Osteoporos Rep. 2008 Jun;6(2):51-6. doi: 10.1007/s11914-008-0009-5. Curr Osteoporos Rep. 2008. PMID: 18778563

7

Inhibin A is an endocrine stimulator of bone mass and strength.

Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL, Skinner RA, Hogue WR, Nicks KM, Pierson TM, Suva LJ, Gaddy D. Perrien DS, et al. Endocrinology. 2007 Apr;148(4):1654-65. doi: 10.1210/en.2006-0848. Epub 2006 Dec 28. Endocrinology. 2007. PMID: 17194739

8

Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.

Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S, Gaddy D. Perrien DS, et al. J Clin Endocrinol Metab. 2006 May;91(5):1848-54. doi: 10.1210/jc.2005-2423. Epub 2006 Jan 31. J Clin Endocrinol Metab. 2006. PMID: 16449331

9

Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures.

Fowler TW, Kamalakar A, Akel NS, Kurten RC, Suva LJ, Gaddy D. Fowler TW, et al. J Cell Sci. 2015 Feb 15;128(4):683-94. doi: 10.1242/jcs.157834. Epub 2015 Jan 20. J Cell Sci. 2015. PMID: 25609708 Free PMC article.

10

Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures.

Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC. Gaddy-Kurten D, et al. Endocrinology. 2002 Jan;143(1):74-83. doi: 10.1210/endo.143.1.8580. Endocrinology. 2002. PMID: 11751595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year